# Sources — Jackie Robinson

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Swaine R. “Jackie Robinson,” SABR BioProject (Society for American Baseball Research). Supports his birth on January 31, 1919, in Cairo, Georgia; his first game for the Brooklyn Dodgers on April 15, 1947; the announcement of his retirement on January 22, 1957; that he acknowledged his diabetes a few years after retiring; and his fatal heart attack at 53 at his home in Stamford, Connecticut, on October 24, 1972. https://sabr.org/bioproj/person/jackie-robinson/
2. California State Legislature. Assembly Concurrent Resolution No. 197 (2016), chaptered. Supports his birth in Cairo, Georgia, to a family of sharecroppers; his debut on April 15, 1947; that his eldest child, Jackie Jr., died in an automobile accident in 1971; and that he died of heart problems and diabetes complications on October 24, 1972, in Stamford. https://www.leginfo.ca.gov/pub/15-16/bill/asm/ab_0151-0200/acr_197_bill_20160901_chaptered.htm
3. U.S. National Archives. “Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972.” Background supports that by 1972 he had diabetes, hypertension and the effects of several heart attacks, had lost most of his vision, needed a cane, and grieved the deaths of his mentor, his mother and his first son; he died about six months after the letter. https://www.archives.gov/education/lessons/jackie-robinson/letter-1972.html
4. Loeb TB, Morehead-Gee A, Novacek D. “Did racism kill Jackie Robinson?” University of California (UCLA), republished from *The Conversation*, April 8, 2021. Supports his diabetes diagnosis at 37, about the time he retired, kept private at first; diabetes in two of his brothers; high blood pressure; three heart attacks, the third fatal; nerve and artery damage in his legs by 1969, at 50; two mild strokes in 1970; the loss of sight in one eye and limited vision in the other; and that he died almost blind, with diabetes and its complications. https://www.universityofcalifornia.edu/news/did-racism-kill-jackie-robinson
5. Los Angeles Dodgers (MLB.com). “Jackie Robinson Timeline 1950–1979.” Supports his business and NAACP work after baseball and the death of Jackie Robinson Jr. in an automobile accident on June 17, 1971; gives his own death as October 23, 1972 (see Conflicts). https://www.mlb.com/dodgers/history/jackie-robinson/timeline-1950
6. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. American Diabetes Association. Standards of Care in Diabetes—2026, *Diabetes Care* 2026;49(Suppl 1): section 5 on behaviors and well-being (PMID 41358898), 6 on glycemic goals (PMID 41358894), 9 on pharmacologic treatment (PMID 41358900), 10 on cardiovascular disease (PMID 41358899), 11 on chronic kidney disease (PMID 41358881), and 12 on retinopathy, neuropathy and foot care (PMID 41358886). https://pubmed.ncbi.nlm.nih.gov/41358886/
2. Lim JI, et al. Diabetic Retinopathy Preferred Practice Pattern. American Academy of Ophthalmology, *Ophthalmology* 2025 (PMID 39918521): anti-VEGF therapy for center-involving macular edema with vision loss, anti-VEGF or panretinal photocoagulation for proliferative retinopathy, vitrectomy for non-clearing hemorrhage, aspirin not contraindicated, and vision rehabilitation. https://pubmed.ncbi.nlm.nih.gov/39918521/
3. Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). *N Engl J Med* 2016 (PMID 27633186): more retinopathy complications with semaglutide, mainly in people with existing retinopathy and rapid early A1c falls. https://pubmed.ncbi.nlm.nih.gov/27633186/
4. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease (PMID 38743805). https://pubmed.ncbi.nlm.nih.gov/38743805/
5. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (PMID 37471501). https://pubmed.ncbi.nlm.nih.gov/37471501/
6. 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (PMID 34024117). https://pubmed.ncbi.nlm.nih.gov/34024117/
7. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (PMID 40815242). https://pubmed.ncbi.nlm.nih.gov/40815242/
8. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (PMID 38490803). https://pubmed.ncbi.nlm.nih.gov/38490803/
9. International Working Group on the Diabetic Foot. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update) (PMID 37243927). https://pubmed.ncbi.nlm.nih.gov/37243927/
10. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs: A1c every three months while not at goal, potassium and creatinine two to four weeks after starting or increasing an ACE inhibitor or SGLT2 inhibitor, UACR three to six months after a change, lipids four to twelve weeks after a statin change, a foot examination at every visit with loss of sensation, B12 on long-term metformin, and depression screening. https://patrickrutledge.github.io/topthirty/
11. U.S. Preventive Services Task Force: A and B recommendations, depression (2023), colorectal cancer (2021), prostate cancer (2018), HIV (2019), and hepatitis C (2020). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
12. Centers for Disease Control and Prevention. Adult Immunization Schedule by Age. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html
13. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** He died in 1972, so the rule does not apply. The record still keeps to what the cited sources say about his health and adds no illness they do not report beyond the synthetic modern findings described below.
- **Name.** The display name is “Jackie Robinson,” which splits simply into a given and family name, so `identity.name_parts` is not used. His legal given names, which the sources print, are not used anywhere in the record, because one of them is a word in other records’ text and the other is part of other figures’ display names; the record has no alias for the same reason. His son is named once, as “Jackie Robinson Jr.,” in the claim about his death. No other figure who has a record is named.
- **Living people.** His wife and his two younger children are not named; his wife appears only as part of his household. No modern decision, statement or health fact is attributed to any real person; the cardiologist, podiatrist, grief counselor, visiting nurse and retina specialist are fictional or unnamed.
- **What could not be verified and was left out.** The Library of Congress and Britannica pages were blocked; the National Baseball Hall of Fame, the Jackie Robinson Foundation and the New York Times obituary could not be read directly; Arnold Rampersad’s biography was not available. A 1957 diagnosis year attributed to the Library of Congress appeared only in a search snippet and is not cited; other years given on low-quality sites (1941, 1952) are not used. Claims that he was insulin-dependent while playing, that he had a heart attack in 1968, that both legs would need amputation, his physician’s statements, details of his son’s crash, and his son’s earlier struggles are not used. His appearance at the 1972 World Series is not used.
- **Conflicts.** Death date: October 24, 1972 (SABR, California legislature, University of California) is preferred; the Dodgers timeline gives October 23. The year of diagnosis is given only as “at 37, about the time he retired” (CLM-0005, certainty probable), with SABR’s note that he acknowledged it a few years after retiring. The leg, stroke and three-heart-attack facts come from one source each and are marked probable where single-sourced.
- **What is interpretation.** The sources say his near-blindness came from diabetes and its complications but do not name the eye disease; CLM-0009 records diabetic retinopathy as the likely cause, graded **R**. The earlier heart attacks are not dated, so the modern episode records coronary disease found on a stress test and no prior heart attack, to avoid placing an undated event before the index date.
- **Index age and dates.** The index visit on July 27, 2026 maps to July 27, 1971, when he was 52: six weeks after his son’s death, two years after the documented leg damage, the year after two mild strokes, and fifteen months before his death. The synthetic date of birth is January 31, 1974 (shift 55 years). Visits on July 29, August 17, August 26, September 21 and October 26, 2026, and the retina, cardiology and laser dates between them, map to the same days of 1971. His home in Stamford comes from the death claim; no source dates his move there, so it is used only in the social history. Past medical history includes only the diagnosis of diabetes (about 1957), the leg damage (by 1969) and the strokes (1970).
- **Synthetic clinical picture.** Following the presenting-problem pattern, intake records blurred vision with floaters (H53.8), resolved two days later when the retina specialist diagnosed proliferative retinopathy with center-involving macular edema in both eyes (E11.3513) and a right vitreous hemorrhage (H43.11), and exertional chest tightness (R07.89), resolved at the sick visit when the stress test established coronary disease with stable angina (I25.119). Intake text shows only what was known at intake. Diabetes with hyperglycemia, hypertension with albuminuric kidney disease (I12.9, E11.22, N18.2), peripheral artery disease (E11.51), neuropathy (E11.42), the history of strokes (Z86.73), hyperlipidemia and bereavement (Z63.4) are recorded at intake; those with documented anchors are linked to their claims. Every value, image, acuity, thickness, index, score and medicine is synthetic. Height (180 cm) and weights are synthetic. Qualitative results (ECG, fundus and B-scan findings, stress test, PSA, HIV, hepatitis C) appear only in note text.
- **Glucose lowering and the retina.** The modern plan lowers A1c by about a point every three months (10.4% to 9.2%), starts empagliflozin first, and starts dulaglutide (not semaglutide) at the lowest dose only after the retina specialist judged the proliferative disease controlled, with monthly retina review, as the teaching point on early worsening requires. This is a judgment call: guidelines do not forbid GLP-1 receptor agonists in retinopathy, and the record presents the delay as a shared decision, not a rule.
- **Grief and mood.** His son’s death (CLM-0011) and his grief (CLM-0012) are marked sensitive. Grief is coded as bereavement (Z63.4), not as a mental disorder. PHQ-9 is 9 at intake and 6 at three months, PHQ-2 is 2, and item 9 is 0, so no safety assessment is required; the 988 line is still named in the plan. Grief counseling at the health center is synthetic.
- **Equity.** The record treats access and outcomes as part of the plan: a 48-hour retina visit instead of a routine one, low-vision services and accessible diabetes tools, a vascular and foot program that aims to prevent amputation, and shared decisions on prostate screening that name the higher risk in Black men. The University of California article on stress and health disparities is used only for its health facts; no claim is made about the causes of his illness.
- **Sick visit.** A neuropathic friction blister on the right heel from new shoes (S90.821A), found late because of numb feet and low vision, treated with wound care, offloading, a visiting nurse and podiatry, healed in five weeks. It interacts with his neuropathy, artery disease and vision and does not echo a documented event. The same visit records the cardiology result.
- **Preventive visit.** A periodic adult preventive visit at 52 (CPT 99396 and 99497 in plain text): colonoscopy chosen, with written medicine instructions for the preparation; PSA after shared decision-making; HIV and hepatitis C once; influenza, PCV20 and zoster dose 1 given, COVID-19 and hepatitis B at the next visit; advance care planning with an unnamed agent.
- **Focused visits.** The three chronic-care follow-ups (two days with the consultation, four weeks, and three months) are documented as focused visits on the ADA Standards of Care 2026, the AAO Preferred Practice Pattern 2025, the 2024 ACC/AHA PAD guideline, the 2023 chronic coronary disease guideline, KDIGO 2024, IWGDF 2023 and the CMID monographs. One deviation is recorded instead of an invented result: the lipid panel due 4 to 12 weeks after the atorvastatin increase was not ordered at the four-week visit and was drawn at thirteen weeks; no harm (LDL 74 mg/dL), and the next panel, after ezetimibe, was booked before he left. The retina injections, OCT, laser, stress test and wound care are recorded as procedures on their own dates.
- **Consultation.** The referral and the consultation by Priya Ostrowski-Lane, MD (a fictional retina specialist), two days after intake, are **S**. The assigned surname was changed to “Ostrowski-Lane” because its second part is a word in another figure’s display name. The consultant answers the six referral questions in line with what the record shows afterwards: proliferative retinopathy with macular edema in both eyes and an attached right retina; monthly aflibercept for three doses (given), laser to the right eye when the blood cleared (done), vitrectomy only if it did not clear (not needed); a gradual A1c fall and a GLP-1 receptor agonist after the retina was stable (dulaglutide at three months, with her agreement); aspirin continued; low-vision services (done) and no driving; and monthly retina visits.
